R333 (Pantoprazole Sodium Delayed Release 40 mg)
Pill with imprint R333 is Yellow, Round and has been identified as Pantoprazole Sodium Delayed Release 40 mg. It is supplied by Dr. Reddy’s Laboratories Inc..
Pantoprazole is used in the treatment of barrett's esophagus; gerd; dumping syndrome; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for R333
- 40 mg
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Dr. Reddy’s Laboratories Inc.
- Inactive Ingredients:
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol 400
ferric oxide yellow
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
|NDC Code||Labeler / Repackager|
More about pantoprazole
- Pantoprazole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 149 Reviews
- Drug class: proton pump inhibitors
- Pantoprazole Delayed-Release Tablets
- Pantoprazole Delayed-Release Granules
- Pantoprazole Injection
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.